In a startling development that has gripped both the entertainment and legal worlds, Jasveen Sangha, infamously dubbed the "Ketamine Queen" by US prosecutors, stands accused of a series of grave offenses linked to the death of actor Matthew Perry. Allegations against Sangha include nine charges, such as conspiracy to distribute ketamine and distribution of ketamine resulting in death. Her case has attracted significant media attention, particularly given her reputed connections to high-profile celebrities and the controversial nature of the charges.
The crux of the indictment revolves around an incident on October 24, 2023, when it is alleged that Sangha’s distribution of ketamine led to Perry’s fatal overdose. Ketamine, a dissociative anesthetic with hallucinogenic properties, is known for its capacity to distort perceptions and induce a feeling of detachment from reality. According to the US Drug Enforcement Administration, the drug is typically used under strict medical supervision, due to its potential for harmful effects if misused.
Sangha’s alleged involvement in the ketamine trade is highlighted by the discovery of her so-called "stash house" in North Hollywood. This residence, described as a "drug-selling emporium" by Martin Estrada, the US Attorney for California's Central District, was raided by authorities. The search reportedly yielded over 80 vials of ketamine, as well as thousands of pills including methamphetamine, cocaine, and Xanax. The house, according to the indictment, was a hub for the packaging and distribution of these illicit substances.
Furthermore, the indictment cites testimony from co-accused Erik Fleming, who described Sangha as someone who "only deals with high end and celebs." This characterization aligns with Sangha’s high-profile social media presence, which frequently showcased her extravagant lifestyle. Her posts included glamorous parties and international trips, such as a visit to Japan, shortly after Perry's death. Such revelations have added a layer of intrigue to the case, underscoring the stark contrast between her public persona and the alleged criminal activities.
Prosecutors also claim that Sangha’s connection to Perry was facilitated through fellow defendants Dr. Salvador Plasencia and Dr. Mark Chavez, who were involved in the ketamine supply chain. Dr. Plasencia reportedly introduced Perry to ketamine, and Sangha is said to have started supplying ketamine to Perry’s assistant, Kenneth Iwamasa, from October 2023 onwards. This sequence of events highlights the alleged negligence and recklessness with which the defendants treated Perry's well-being.
In addition to the charges related to Perry’s death, US authorities have uncovered evidence linking Sangha to another overdose case from 2019. Court documents indicate that she sold ketamine to Cody McLaury, who subsequently died of an overdose. Sangha reportedly received a text from McLaury's family, accusing her of causing his death, which led her to search online about ketamine being listed as a cause of death. This connection further complicates her legal troubles, as it underscores a pattern of alleged misconduct.
Despite her plea of not guilty, Sangha’s bail request was denied, and she will remain in custody until her trial begins in October. If convicted of all charges, she faces a mandatory minimum sentence of 10 years in federal prison, with a potential maximum of life imprisonment. The severity of the charges, combined with the high-profile nature of the case, has placed Sangha under intense scrutiny from both the media and the public.
As the legal proceedings continue, the case against Jasveen Sangha remains a focal point in discussions about drug trafficking and its intersection with celebrity culture. The dramatic revelations and the complex network of individuals involved make this case one of the most intriguing and significant drug-related trials in recent memory.
